Added to website. Tabular highlights gives a high level view of how iPRECIO pumps were used/programmed in selected scientific publications in Applications Examples eBook < here >.

Neuroscience 2018. iPRECIO Micro Infusion Pump on booth 2922. Ask us for our recently updated Example Applications & much more booklet for Neuroscience 2018 which summarizes data from peer reviewed articles and presentations. Preliminary 310R specifications published < here >.

United States Patent Application 20180161282 Methods and compositions for the treatment of seizure-related disorders by Adamas Biopharmaceutical Inc. (https://www.adamaspharma.com/) includes references to iPRECIO Micro Infusion Pump use in Examples 13 to 16. In example 13, “The PK parameters (Cmax, Tmax, T1/2, AUC) of 200 mg IR lacosamide BID and 400 mg ER lacosamide QD in humans can be replicated in rats using programmable subcutaneous infusion pumps. ”. For more information, see https://patents.google.com/ or http://appft.uspto.gov.

"The iPRECIO pump enables reliable, timed delivery of pharmacological agents. The pump was programmed for 1 hour delivery of Isoproterenol at 30ul/hr, total dose of 2mg/kg/day, once a day at the same time (1pm)” 4/5 week study duration.

Swati Dey et al., Mitochondrial ROS Drive Sudden Cardiac Death and Chronic Proteome Remodeling in Heart Failure Circulation Research. 2018;CIRCRESAHA.118.312708, originally published June 13, 2018 https://doi.org/10.1161/CIRCRESAHA.118.312708

RenaSci (http://www.renasci.co.uk/news/iprecio-micro-infusion-pumps) are now offering chronic administration of drugs via implantable, programmable, refillable, micro infusion iPRECIO^® pumps.